Preprint Review Version 1 This version is not peer-reviewed

Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions

Version 1 : Received: 8 August 2024 / Approved: 8 August 2024 / Online: 9 August 2024 (03:58:48 CEST)

How to cite: Pham, T. D.; Teh, M.-T.; Chatzopoulou, D.; Holmes, S.; Coulthard, P. Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions. Preprints 2024, 2024080630. https://doi.org/10.20944/preprints202408.0630.v1 Pham, T. D.; Teh, M.-T.; Chatzopoulou, D.; Holmes, S.; Coulthard, P. Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions. Preprints 2024, 2024080630. https://doi.org/10.20944/preprints202408.0630.v1

Abstract

Artificial Intelligence (AI) is revolutionizing head and neck cancer (HNC) care by providing innovative tools that enhance diagnostic accuracy and personalize treatment strategies. This review highlights the advancements in AI technologies, including deep learning and natural language processing, and their applications in HNC. The integration of AI with imaging techniques, genomics, and electronic health records is explored, emphasizing its role in early detection, biomarker discovery, and treatment planning. Despite noticeable progress, challenges such as data quality, algorithmic bias, and the need for interdisciplinary collaboration remain. Emerging innovations like explainable AI, AI-powered robotics, and real-time monitoring systems are poised to further advance the field. Addressing these challenges and fostering collaboration among AI experts, clinicians, and researchers is crucial for developing equitable and effective AI applications. The future of AI in HNC holds significant promise, offering potential breakthroughs in diagnostics, personalized therapies, and improved patient outcomes.

Keywords

artificial intelligence; head and neck cancer; oral cancer; imaging techniques; deep learning; natural language processing; early detection; personalized treatment; biomarker discovery; explainable machine intelligence

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.